229 related articles for article (PubMed ID: 34504250)
1. Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure.
Flamant M; Mougenot N; Balse E; Le Fèvre L; Atassi F; Gautier EL; Le Goff W; Keck M; Nadaud S; Combadière C; Boissonnas A; Pavoine C
Sci Rep; 2021 Sep; 11(1):17982. PubMed ID: 34504250
[TBL] [Abstract][Full Text] [Related]
2. Antagonizing the CX3CR1 Receptor Markedly Reduces Development of Cardiac Hypertrophy After Transverse Aortic Constriction in Mice.
Nemska S; Gassmann M; Bang ML; Frossard N; Tavakoli R
J Cardiovasc Pharmacol; 2021 Dec; 78(6):792-801. PubMed ID: 34882111
[TBL] [Abstract][Full Text] [Related]
3. The CX3CL1/CX3CR1 axis is upregulated in chronic kidney disease and contributes to angiotensin II-induced migration of vascular smooth muscle cells.
Li C; Zhong X; Xia W; He J; Gan H; Zhao H; Xia Y
Microvasc Res; 2020 Nov; 132():104037. PubMed ID: 32615135
[TBL] [Abstract][Full Text] [Related]
4. The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice.
Yu YW; Li MX; Zhang ZY; Yu H
Int J Mol Med; 2018 Jun; 41(6):3577-3585. PubMed ID: 29568873
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1 axis in a Niemann-Pick disease type C1 model.
Seo Y; Kim HS; Kang I; Choi SW; Shin TH; Shin JH; Lee BC; Lee JY; Kim JJ; Kook MG; Kang KS
Glia; 2016 Dec; 64(12):2291-2305. PubMed ID: 27687148
[TBL] [Abstract][Full Text] [Related]
6. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
[TBL] [Abstract][Full Text] [Related]
7. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure.
Husberg C; Nygård S; Finsen AV; Damås JK; Frigessi A; Oie E; Waehre A; Gullestad L; Aukrust P; Yndestad A; Christensen G
J Mol Cell Cardiol; 2008 Aug; 45(2):261-9. PubMed ID: 18585734
[TBL] [Abstract][Full Text] [Related]
8. CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway.
Wu XM; Liu Y; Qian ZM; Luo QQ; Ke Y
Mol Neurobiol; 2016 Aug; 53(6):4010-4018. PubMed ID: 26189830
[TBL] [Abstract][Full Text] [Related]
9. Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis.
Zhang P; Wang BJ; Wang JZ; Xie XM; Tong QX
Curr Med Sci; 2020 Dec; 40(6):1121-1127. PubMed ID: 33428140
[TBL] [Abstract][Full Text] [Related]
10. Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling.
Frias-Anaya E; Gallego-Gutierrez H; Gongol B; Weinsheimer S; Lai CC; Orecchioni M; Sriram A; Bui CM; Nelsen B; Hale P; Pham A; Shenkar R; DeBiasse D; Lightle R; Girard R; Li Y; Srinath A; Daneman R; Nudleman E; Sun H; Guma M; Dubrac A; Mesarwi OA; Ley K; Kim H; Awad IA; Ginsberg MH; Lopez-Ramirez MA
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1246-1264. PubMed ID: 38660801
[TBL] [Abstract][Full Text] [Related]
11. CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis.
Helmke A; Nordlohne J; Balzer MS; Dong L; Rong S; Hiss M; Shushakova N; Haller H; von Vietinghoff S
Kidney Int; 2019 Jun; 95(6):1405-1417. PubMed ID: 30948201
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
Cormican S; Griffin MD
Front Immunol; 2021; 12():664202. PubMed ID: 34163473
[TBL] [Abstract][Full Text] [Related]
13. CX3CL1/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status.
Ni Y; Zhuge F; Ni L; Nagata N; Yamashita T; Mukaida N; Kaneko S; Ota T; Nagashimada M
Metabolism; 2022 Nov; 136():155272. PubMed ID: 35914622
[TBL] [Abstract][Full Text] [Related]
14. Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes.
Park Y; Lee J; Kwak JY; Noh K; Yim E; Kim HK; Kim YJ; Broxmeyer HE; Kim JA
J Leukoc Biol; 2018 Jan; 103(1):53-66. PubMed ID: 28978662
[TBL] [Abstract][Full Text] [Related]
15. Prevention of lipopolysaccharide-induced preterm labor by the lack of CX3CL1-CX3CR1 interaction in mice.
Mizoguchi M; Ishida Y; Nosaka M; Kimura A; Kuninaka Y; Yahata T; Nanjo S; Toujima S; Minami S; Ino K; Mukaida N; Kondo T
PLoS One; 2018; 13(11):e0207085. PubMed ID: 30399192
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of CX3CL1 Attenuates TGF-β-Induced Fibroblast Differentiation Through NF-κB Activation and Mitochondrial Dysfunction in Airway Fibrosis.
Cheng WH; Chang PL; Wu YC; Wang SA; Chen CL; Hsu FL; Neoh MM; Lin LY; Yuliani FS; Lin CH; Chen BC
Lung; 2024 Jun; 202(3):343-356. PubMed ID: 38678499
[TBL] [Abstract][Full Text] [Related]
17. CX3CL1-CX3CR1 Signaling Deficiency Exacerbates Obesity-induced Inflammation and Insulin Resistance in Male Mice.
Nagashimada M; Sawamoto K; Ni Y; Kitade H; Nagata N; Xu L; Kobori M; Mukaida N; Yamashita T; Kaneko S; Ota T
Endocrinology; 2021 Jun; 162(6):. PubMed ID: 33765141
[TBL] [Abstract][Full Text] [Related]
18. Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration.
Ishida Y; Kimura A; Nosaka M; Kuninaka Y; Hemmi H; Sasaki I; Kaisho T; Mukaida N; Kondo T
Sci Rep; 2017 Dec; 7(1):16833. PubMed ID: 29203799
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-195 prevents hippocampal microglial/macrophage polarization towards the M1 phenotype induced by chronic brain hypoperfusion through regulating CX3CL1/CX3CR1 signaling.
Mao M; Xu Y; Zhang XY; Yang L; An XB; Qu Y; Chai YN; Wang YR; Li TT; Ai J
J Neuroinflammation; 2020 Aug; 17(1):244. PubMed ID: 32819407
[TBL] [Abstract][Full Text] [Related]
20. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
